Dopamine receptor antagonist related to metoclopramide, q.v. Prepn: R. G. Spickett et al., DE 2513136; A. V. Noverola et al., US 4138492 (1975, 1979 both to Anphar); J. Prieto et al., J. Pharm. Pharmacol. 29, 147 (1977). Pharmacological study: J. L. Masso, D. J. Roberts, ibid. 32, 727 (1980). In vitro metabolism studies: G. Huizing et al., Xenobiotica 10, 211 (1980); G. Huizing, A. H. Beckett, ibid. 593. Pharmacokinetics: J. Segura et al., J. Pharm. Pharmacol. 33, 214 (1981). Comparative study of anti-emetic and gastrointestinal effects: P. Berga et al., Arch. Farmacol. Toxicol. 7, 189 (1981). Efficacy in healing exptl ulcers: Y. Matsuo et al., Oyo Yakuri 24, 251 (1982); S. Okabe et al., ibid. 261, C.A. 97, 208081n, 208082p (1982). Determn in urine and plasma by radioimmunoassay: M. Yano et al., Chem. Pharm. Bull. 32, 1491 (1984). Clinical effect in postoperative nausea: D. F. Duarte et al., Clin. Ther. 7, 365 (1985).
Antiemetic; antispasmodic.
Antiemetic; Antispasmodic; Dopamine Receptor Antagonist